Institutional Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$55.8M Sell
783,880
-1,025,102
-57% -$80.5M 0.83% 33
2016
Q3
$156M Sell
1,808,982
-449,993
-20% -$39.2M 2.15% 22
2016
Q2
$196M Sell
2,258,975
-1,573,364
-41% -$127M 2.4% 21
2016
Q1
$287M Sell
3,832,339
-1,489,854
-28% -$112M 3.06% 16
2015
Q4
$409M Sell
5,322,193
-1,757,125
-25% -$132M 3.55% 7
2015
Q3
$474M Sell
7,079,318
-1,522,229
-18% -$112M 3.96% 3
2015
Q2
$637M Buy
8,601,547
+112,890
+1% +$8.63M 4.46% 1
2015
Q1
$662M Buy
8,488,657
+2,910,035
+52% +$221M 4.07% 5
2014
Q4
$403M Sell
5,578,622
-586,578
-10% -$40.7M 2.42% 20
2014
Q3
$382M Buy
+6,165,200
New +$392M 2.23% 21

Other funds holding MDT

Institutional Capital's MDT Position: Q4 2016 in Review

Institutional Capital reduced its Medtronic (MDT) stake by 57% in Q4 2016, selling an estimated $80.5M and leaving 783,880 shares worth $55.8M. The position accounts for 0.83% of the portfolio, ranked #33.

Institutional Capital first reported a position in MDT in Q3 2014 and has held it in 10 quarters since. The position peaked at $662M in Q1 2015. 1,268 funds tracked by Wall St. Rank hold MDT as of Q4 2016.

  • Institutional Capital held 783,880 shares of Medtronic worth $55.8M as of Q4 2016.
  • Institutional Capital sold 1,025,102 Medtronic shares in Q4 2016, an estimated $80.5M.
  • Medtronic made up 0.83% of Institutional Capital's portfolio in Q4 2016, its #33 holding.
  • Institutional Capital first reported a position in Medtronic in Q3 2014 and has held it in 10 quarters since.
  • Institutional Capital's Medtronic position peaked at $662M in Q1 2015.
  • 1,268 funds tracked by Wall St. Rank held Medtronic as of Q4 2016.

Based on Institutional Capital's 13F filing for Q4 2016, filed 2 Feb 2017.